Literature DB >> 17592348

Quantitative evaluation of the neuroprotective effects of thiopental sodium, propofol, and halothane on brain ischemia in the gerbil: effects of the anesthetics on ischemic depolarization and extracellular glutamate concentration.

Motomu Kobayashi1, Yoshimasa Takeda, Hideki Taninishi, Ken Takata, Hisami Aoe, Kiyoshi Morita.   

Abstract

Although propofol and thiopental are commonly used as neuroprotective agents, it has not been determined which is more neuroprotective. This study was designed to quantitatively evaluate the neuroprotective effects of thiopental, propofol, and halothane on brain ischemia by determining P50, ischemic time necessary for causing 50% neuronal damage. Gerbils were anesthetized with thiopental, propofol, or halothane and underwent 2-vessel occlusion (0, 3, 5 or 10 min). Direct current potentials were measured in bilateral CA1 regions, in which histologic evaluation was performed 5 days later. In some animals, extracellular glutamate concentrations (microdialysis) were measured during 7.5 minutes of ischemia. P50 in the thiopental, propofol, and halothane groups were estimated to be 8.4, 6.5 (P<0.05, vs. thiopental), and 5.1 (P<0.05) minutes, respectively. Durations of ischemic depolarization were equally reduced in the thiopental and propofol groups compared with that in the halothane group. Severity of neuronal damage with identical duration of ischemic depolarization was attenuated by thiopental compared with the effect of propofol. Maximum glutamate concentrations in the thiopental and propofol group were significantly reduced compared with that in the halothane groups but were comparable. By using P50, we found that the neuroprotective effect of thiopental was greater than that of propofol. Although duration of ischemic depolarization was equally reduced in thiopental and propofol groups, thiopental has a greater suppressive effect on neuronal injury during identical duration of ischemic depolarization than propofol does. Glutamate concentration during brain ischemia tended to be attenuated more by thiopental than by propofol, but it was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592348     DOI: 10.1097/ANA.0b013e318051743d

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  6 in total

Review 1.  Anesthesia in Experimental Stroke Research.

Authors:  Ulrike Hoffmann; Huaxin Sheng; Cenk Ayata; David S Warner
Journal:  Transl Stroke Res       Date:  2016-08-17       Impact factor: 6.829

Review 2.  Anaesthetic-related neuroprotection: intravenous or inhalational agents?

Authors:  Daniela Schifilliti; Giovanni Grasso; Alfredo Conti; Vincenzo Fodale
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  Metabotropic actions of the volatile anaesthetic sevoflurane increase protein kinase M synthesis and induce immediate preconditioning protection of rat hippocampal slices.

Authors:  Jun Wang; Fanli Meng; James E Cottrell; Todd C Sacktor; Ira S Kass
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

4.  Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced neuroprotection against cerebral ischemic injuries of mice.

Authors:  Luowa Shu; Tianzuo Li; Song Han; Fang Ji; Chuxiong Pan; Bingxi Zhang; Junfa Li
Journal:  Neurochem Res       Date:  2011-09-03       Impact factor: 3.996

5.  Expression of CCL2 and CCR2 in the hippocampus and the interventional roles of propofol in rat cerebral ischemia/reperfusion.

Authors:  Yong-Qing Guo; Li-Na Zheng; Jian-Feng Wei; Xiao-Lai Hou; Shu-Zhen Yu; Wei-Wei Zhang; Jian-Min Jing
Journal:  Exp Ther Med       Date:  2014-06-04       Impact factor: 2.447

6.  Thiopental sodium loaded solid lipid nano-particles attenuates obesity-induced cardiac dysfunction and cardiac hypertrophy via inactivation of inflammatory pathway.

Authors:  Canzhan Zhu; Wanjing Li; Xinhong Wang; Jiahong Xue; Ling Zhao; Yafan Song; Tian Zhou; Mingjuan Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.